当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析

明德生物

(002932)

  

流通市值:30.26亿  总市值:45.09亿
流通股本:1.56亿   总股本:2.33亿

明德生物(002932)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.07亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益574654.48万元,未分配利润413233.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产615414.79万元,负债40760.30万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入139,289,387.4169,960,271.6350,061,800.61225,617,843.38
营业总成本206,076,837.66114,191,703.22432,523,176.2319,893,245.81
其他经营收益
营业利润9,478,291.8-2,427,213.4841,186,901.8982,281,071.77
利润总额6,800,957.58-3,969,638.7832,415,968.4278,074,642.8
净利润6,625,836.4-3,405,173.9926,564,716.4962,363,772.16
每股收益
其他综合收益----
综合收益总额6,625,836.4-3,405,173.9926,564,716.4962,363,772.16
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计4,765,113,385.24,306,916,741.272,397,670,406.852,120,880,457.63
非流动资产:
非流动资产合计1,389,034,470.82,192,485,320.364,195,408,189.054,709,060,724.79
资产总计6,154,147,8566,499,402,061.636,593,078,595.96,829,941,182.42
流动负债:
流动负债合计329,069,835.86421,478,788.73495,856,537.68645,171,910.76
非流动负债:
非流动负债合计78,533,195.4778,254,258.3878,544,618.274,447,114.75
负债合计407,603,031.33499,733,047.11574,401,155.88719,619,025.51
所有者权益(或股东权益):
归属于母公司股东权益合计5,565,731,237.35,807,125,824.335,826,392,063.95,888,448,333.17
股东权益合计5,746,544,824.675,999,669,014.526,018,677,440.026,110,322,156.91
负债和股东权益合计6,154,147,8566,499,402,061.636,593,078,595.96,829,941,182.42
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计306,029,581.96154,356,495.64946,613,595.02689,598,336.84
经营活动现金流出小计393,685,592.28184,880,983.971,031,660,034.59812,864,780.68
经营活动产生的现金流量净额-87,656,010.32-30,524,488.33-85,046,439.57-123,266,443.84
投资活动产生的现金流量:
投资活动现金流入小计510,402,212.3731,992,423.78772,300,848.49423,910,028.25
投资活动现金流出小计288,569,180.59127,015,255.12910,425,484.33568,653,644.73
投资活动产生的现金流量净额221,833,031.78-95,022,831.34-138,124,635.84-144,743,616.48
筹资活动产生的现金流量:
筹资活动现金流入小计--21,876,745.990
筹资活动现金流出小计279,241,137.0315,635,616.79335,045,214.85250,643,991.12
筹资活动产生的现金流量净额-279,241,137.03-15,635,616.79-313,168,468.86-250,643,991.12
汇率变动对现金及现金等价物的影响-176,613.02-37,577.57506,232.79-1,049,547.18
现金及现金等价物净增加额-145,240,728.59-141,220,514.03-535,833,311.48-519,703,598.62
期末现金及现金等价物余额232,965,834.91236,986,049.47378,206,563.5394,336,276.36
补充资料:
现金及现金等价物的净增加额-145,240,728.59--535,833,311.48-
TOP↑